Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer's Disease.

Paul Loyd WheelerClaire Murphy
Published in: Brain sciences (2021)
Olfactory biomarkers show real promise as non-invasive indicators of prodromal AD. The results support the value of combining olfactory measures in assessment of risk for conversion to MCI and to AD.